76 related articles for article (PubMed ID: 17223452)
21. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
22. [Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
Rumiantseva IuV; Karachunskiĭ AI; Aleĭnikova OV; Fechina LG; Shamardina AV; Litvinov DV; Ponomareva NI; Boĭchenko EG; Dudkin SA; Streneva OV; Kondratchik KL; Mansurova EG; Minkina LM; Lapotentova ES; Iniushkina EV; Iudina NB; Pavlova GP; Zhukovskaia EV; Khlebnikova OP; Lagoĭko SN; Basharova EV; Denisov RE; Zlobina VD; Banshchikova ES; Aslanian KS; Kondakova EV; Tselousova EV; Miakova NV; Turobova TV; Ryskal' OV; Chipsanova NF; Varfolomeeva SR; Rumiantsev AG
Ter Arkh; 2010; 82(7):11-9. PubMed ID: 20853603
[TBL] [Abstract][Full Text] [Related]
23. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Henze G; v Stackelberg A; Eckert C
Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation in acute lymphocytic leukemia (ALL).
Dicke KA; Spinolo JA
Leukemia; 1992; 6 Suppl 2():136-8. PubMed ID: 1578916
[No Abstract] [Full Text] [Related]
25. [Current status of the treatment of acute lymphocytic leukemia in the adult].
Shi YD; Zhang ZN
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):499-502. PubMed ID: 2689108
[No Abstract] [Full Text] [Related]
26. A randomized trial of dexamethasone before remission induction, in de novo childhood acute lymphoblastic leukemia.
López-Hernández MA; Alvarado M; De Diego J; Borbolla-Escoboza JR; Jiménez RM; Trueba E
Haematologica; 2004 Mar; 89(3):365-6. PubMed ID: 15020281
[TBL] [Abstract][Full Text] [Related]
27. Acute lymphoblastic leukemia in infants.
Gürgey A; Yetgin S; Cetin M; Gümrük F; Tuncer AM; Tunçbilek E; Hiçsönmez G
Turk J Pediatr; 2004; 46(2):115-9. PubMed ID: 15214738
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of childhood acute leukemia: a long-term follow-up study of CCLSG-high risk ALL 811 (phase III study). Children's Cancer & Leukemia Study Group].
Mimaya J; Fujimoto T; Takeda T; Yanai M; Yatabe M; Utumi J; Hiyosi Y; Koizumi S; Tanaka K; Yaoi K
Rinsho Ketsueki; 1988 Sep; 29(9):1357-64. PubMed ID: 3063852
[No Abstract] [Full Text] [Related]
29. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
31. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
[No Abstract] [Full Text] [Related]
32. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Ochocka M; Zelenay E
Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
[No Abstract] [Full Text] [Related]
33. Efficacy and toxicity of dexamethasone vs methylprednisolone-long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002.
Karachunskiy A; Roumiantseva J; Lagoiko S; Bührer C; Tallen G; Aleinikova O; Bydanov O; Korepanova N; Bajdun L; Nasedkina T; von Stackelberg A; Novichkova G; Maschan A; Litvinov D; Myakova N; Ponomareva N; Kondratchik K; Fechina L; Streneva O; Judina N; Scharapova G; Shamardina A; Gerbek I; Shapochnik A; Rumjanzew A; Henze G;
Leukemia; 2015 Sep; 29(9):1955-8. PubMed ID: 25748686
[No Abstract] [Full Text] [Related]
34. Maintenance chemotherapy of acute lymphoblastic leukemia in children.
Schmiegelow K
Dan Med Bull; 1998 Nov; 45(5):510-32. PubMed ID: 9850812
[No Abstract] [Full Text] [Related]
35. [Second cessation of therapy in children with acute lymphoblastic leukemia].
Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
[TBL] [Abstract][Full Text] [Related]
36. All dex'ed out with nowhere to go?
Adamson PC; Barrett JS
J Clin Oncol; 2008 Apr; 26(12):1917-8. PubMed ID: 18421043
[No Abstract] [Full Text] [Related]
37. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
Hijiya N; Stewart CF; Zhou Y; Campana D; Coustan-Smith E; Rivera GK; Relling MV; Pui CH; Gajjar A
Cancer; 2008 May; 112(9):1983-91. PubMed ID: 18318429
[TBL] [Abstract][Full Text] [Related]
39. Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial.
Schrappe M
Lancet; 2010 Dec; 376(9757):1968-70. PubMed ID: 21131040
[No Abstract] [Full Text] [Related]
40. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]